Pharm. Ahmed Yakasai, a former president of the Pharmaceutical Society of Nigeria, has been appointed the director of Silvercrest Consultants Hospital, marking a significant addition to the hospital’s leadership structure.
The appointment was ratified at the institution’s 3rd Board Meeting, where members unanimously endorsed Yakasai’s inclusion based on his track record of excellence in the healthcare and pharmaceutical sectors.
In acknowledging the appointment, Yakasai expressed deep gratitude to the Chairman and Members of the Board for considering him worthy of joining the governance team of the fast-growing hospital. He described the honour as a privilege that reflects the institution’s trust in his professional pedigree and decades of service within Nigeria’s healthcare ecosystem.
According to the appointment letter shared with Pharmanewsonline, the decision to bring Yakasai on board was informed by his cognate experience, extensive industry expertise, and notable accomplishments over the years. These qualities, the Board noted, aligned perfectly with the hospital’s vision of strengthening its leadership with seasoned professionals who can drive innovation and strategic expansion.
Yakasai, a respected leader in the pharmaceutical community, is known for his contributions to healthcare reforms, advocacy, and institutional development. His appointment is expected to further reinforce the hospital’s commitment to quality care, operational excellence, and improved service delivery across its various departments.
Reacting to the development, he stated that he was humbled by the confidence reposed in him, adding that the opportunity to serve on the Board comes with a renewed sense of responsibility. He assured stakeholders that he would work collaboratively with other directors to advance the hospital’s mission and long-term objectives.
He further pledged unwavering commitment, loyalty, and dedication to the advancement of Silvercrest Consultants Hospital. Yakasai emphasized that his focus would be on contributing meaningfully to the hospital’s strategic growth, strengthening its governance frameworks, and supporting initiatives aimed at elevating healthcare outcomes.
The Board, on its part, expressed optimism that Yakasai’s entry would bring fresh perspectives and deepen institutional capacity. His vast experience in administration, regulatory matters, and public health leadership is expected to be instrumental as the hospital intensifies efforts to expand its footprint and enhance service quality.
With this appointment, Silvercrest Consultants Hospital continues to build a formidable leadership team capable of steering the institution into its next phase of development.
Stakeholders within the healthcare sector have also commended the move, describing it as a step that will further position the hospital as a centre of excellence in medical and pharmaceutical services.
